# Tejon Ranch Co: financial statements, quarterly

TRC · NYSE · CIK 96869 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/trc.md) · [Financials](/companies/trc/financials.md) · [Filings](/companies/trc/filings.md) · [Insiders](/companies/trc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/trc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | [7.4](/filings/0001628280-25-023871.md) | [5.7](/filings/0000096869-25-000032.md) | [10.9](/filings/0001628280-25-050104.md) | [17.9 d](/filings/0001628280-26-019685.md) | [8.2](/filings/0001628280-26-033234.md) | [8.3](/filings/0001628280-26-054146.md) | [12.0](/filings/0001628280-25-050104.md) | [21.1 d](/filings/0001628280-26-019685.md) | [9.5](/filings/0001628280-26-033234.md) | [14.3](/filings/0001628280-26-054146.md) |
| Gross profit | $m | not reported | not reported | [0.0](/filings/0001628280-25-023871.md) | [2.6](/filings/0000096869-25-000032.md) | [2.5](/filings/0001628280-25-050104.md) | [7.7 d](/filings/0001628280-26-019685.md) | [1.2](/filings/0001628280-26-033234.md) | [3.5](/filings/0001628280-26-054146.md) | [3.4](/filings/0001628280-25-050104.md) | [6.5 d](/filings/0001628280-26-019685.md) | [2.0](/filings/0001628280-26-033234.md) | [6.8](/filings/0001628280-26-054146.md) |
| Operating income | $m | [0.0](/filings/0000096869-24-000014.md) | [(2.4) d](/filings/0001628280-26-019685.md) | [(4.0)](/filings/0001628280-25-023871.md) | [(3.5)](/filings/0000096869-25-000032.md) | [(3.8)](/filings/0001628280-25-050104.md) | [2.1 d](/filings/0001628280-26-019685.md) | [(4.2)](/filings/0001628280-26-033234.md) | [(4.1)](/filings/0001628280-26-054146.md) | [(2.0)](/filings/0001628280-25-050104.md) | [2.3 d](/filings/0001628280-26-019685.md) | [(1.1)](/filings/0001628280-26-033234.md) | [0.3](/filings/0001628280-26-054146.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [2.2](/filings/0000096869-24-000014.md) | [(1.3) d](/filings/0001628280-26-019685.md) | [(0.9)](/filings/0001628280-25-023871.md) | [(1.2)](/filings/0000096869-25-000032.md) | [1.8](/filings/0001628280-25-050104.md) | [1.3 d](/filings/0001628280-26-019685.md) | [(1.3)](/filings/0001628280-26-033234.md) | [0.4](/filings/0001628280-26-054146.md) | [(1.0)](/filings/0001628280-25-050104.md) | [2.9 d](/filings/0001628280-26-019685.md) | [0.1](/filings/0001628280-26-033234.md) | [0.8](/filings/0001628280-26-054146.md) |
| Net income | $m | [(0.3)](/filings/0000096869-24-000014.md) | [1.6 d](/filings/0001628280-26-019685.md) | [(0.9)](/filings/0001628280-25-023871.md) | [1.0](/filings/0000096869-25-000032.md) | [(1.8)](/filings/0001628280-25-050104.md) | [4.5 d](/filings/0001628280-26-019685.md) | [(1.5)](/filings/0001628280-26-033234.md) | [(1.7)](/filings/0001628280-26-054146.md) | [1.7](/filings/0001628280-25-050104.md) | [1.6 d](/filings/0001628280-26-019685.md) | [0.2](/filings/0001628280-26-033234.md) | [2.6](/filings/0001628280-26-054146.md) |
| Diluted EPS | $ per share | [(0.01)](/filings/0000096869-24-000014.md) | not reported | [(0.03)](/filings/0001628280-25-023871.md) | [0.04](/filings/0000096869-25-000032.md) | [(0.07)](/filings/0001628280-25-050104.md) | not reported | [(0.05)](/filings/0001628280-26-033234.md) | [(0.06)](/filings/0001628280-26-054146.md) | [0.06](/filings/0001628280-25-050104.md) | not reported | [0.01](/filings/0001628280-26-033234.md) | [0.10](/filings/0001628280-26-054146.md) |
| Basic EPS | $ per share | [(0.01)](/filings/0000096869-24-000014.md) | not reported | [(0.03)](/filings/0001628280-25-023871.md) | [0.04](/filings/0000096869-25-000032.md) | [(0.07)](/filings/0001628280-25-050104.md) | not reported | [(0.05)](/filings/0001628280-26-033234.md) | [(0.06)](/filings/0001628280-26-054146.md) | [0.06](/filings/0001628280-25-050104.md) | not reported | [0.01](/filings/0001628280-26-033234.md) | [0.10](/filings/0001628280-26-054146.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [43.1](/filings/0000096869-24-000014.md) | [31.9](/filings/0001628280-26-019685.md) | [35.6](/filings/0001628280-25-023871.md) | [33.0](/filings/0000096869-25-000032.md) | [27.4](/filings/0001628280-25-050104.md) | [39.3](/filings/0001628280-26-019685.md) | [12.3](/filings/0001628280-26-033234.md) | [2.5](/filings/0001628280-26-054146.md) | [3.6](/filings/0001628280-25-050104.md) | [9.5](/filings/0001628280-26-054146.md) | [4.7](/filings/0001628280-26-033234.md) | [3.9](/filings/0001628280-26-054146.md) |
| Current assets | $m | [89.0](/filings/0000096869-23-000017.md) | [79.8](/filings/0000096869-25-000006.md) | [74.7](/filings/0000096869-24-000008.md) | [64.5](/filings/0000096869-24-000011.md) | [55.6](/filings/0000096869-24-000014.md) | [69.4](/filings/0001628280-26-019685.md) | [45.8](/filings/0001628280-25-023871.md) | [33.3](/filings/0000096869-25-000032.md) | [36.6](/filings/0001628280-25-050104.md) | [39.3](/filings/0001628280-26-054146.md) | [33.4](/filings/0001628280-26-033234.md) | [31.7](/filings/0001628280-26-054146.md) |
| Total assets | $m | [580](/filings/0000096869-23-000017.md) | [578](/filings/0001628280-26-019685.md) | [582](/filings/0000096869-24-000008.md) | [591](/filings/0000096869-24-000011.md) | [598](/filings/0000096869-24-000014.md) | [608](/filings/0001628280-26-019685.md) | [615](/filings/0001628280-25-023871.md) | [619](/filings/0000096869-25-000032.md) | [630](/filings/0001628280-25-050104.md) | [630](/filings/0001628280-26-054146.md) | [634](/filings/0001628280-26-033234.md) | [640](/filings/0001628280-26-054146.md) |
| Current liabilities | $m | [18.2](/filings/0000096869-23-000017.md) | [11.6](/filings/0000096869-25-000006.md) | [15.4](/filings/0000096869-24-000008.md) | [18.8](/filings/0000096869-24-000011.md) | [19.6](/filings/0000096869-24-000014.md) | [16.8](/filings/0001628280-26-019685.md) | [17.0](/filings/0001628280-25-023871.md) | [14.8](/filings/0000096869-25-000032.md) | [13.7](/filings/0001628280-25-050104.md) | [9.5](/filings/0001628280-26-054146.md) | [12.1](/filings/0001628280-26-033234.md) | [10.9](/filings/0001628280-26-054146.md) |
| Total liabilities | $m | [99.3](/filings/0000096869-23-000017.md) | [94.4](/filings/0000096869-25-000006.md) | [98.9](/filings/0000096869-24-000008.md) | [106](/filings/0000096869-24-000011.md) | [114](/filings/0000096869-24-000014.md) | [119](/filings/0001628280-26-019685.md) | [127](/filings/0001628280-25-023871.md) | [132](/filings/0000096869-25-000032.md) | [141](/filings/0001628280-25-050104.md) | [140](/filings/0001628280-26-054146.md) | [144](/filings/0001628280-26-033234.md) | [147](/filings/0001628280-26-054146.md) |
| Long-term debt | $m | [46.8](/filings/0000096869-23-000017.md) | [0.0](/filings/0000096869-24-000005.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | [1.8](/filings/0000096869-23-000017.md) | [0.0](/filings/0000096869-24-000005.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [466](/filings/0000096869-23-000017.md) | [468](/filings/0000096869-25-000006.md) | [467](/filings/0000096869-24-000008.md) | [469](/filings/0000096869-24-000011.md) | [468](/filings/0000096869-24-000014.md) | [474](/filings/0001628280-26-019685.md) | [472](/filings/0001628280-25-023871.md) | [472](/filings/0000096869-25-000032.md) | [473](/filings/0001628280-25-050104.md) | [475](/filings/0001628280-26-054146.md) | [475](/filings/0001628280-26-033234.md) | [478](/filings/0001628280-26-054146.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [13.6 d](/filings/0000096869-24-000014.md) | [(1.1) d](/filings/0001628280-26-019685.md) | [0.8](/filings/0001628280-25-023871.md) | [(1.8) d](/filings/0000096869-25-000032.md) | [2.1 d](/filings/0001628280-25-050104.md) | [13.3 d](/filings/0001628280-26-019685.md) | [(1.3)](/filings/0001628280-26-033234.md) | [(0.4) d](/filings/0001628280-26-054146.md) | [(2.4) d](/filings/0001628280-25-050104.md) | [10.2 d](/filings/0001628280-26-019685.md) | [3.3](/filings/0001628280-26-033234.md) | [1.3 d](/filings/0001628280-26-054146.md) |
| Capital expenditure | $m | [3.3 d](/filings/0000096869-24-000014.md) | [7.8 d](/filings/0000096869-25-000006.md) | [8.1](/filings/0001628280-25-023871.md) | [14.0 d](/filings/0000096869-25-000032.md) | [18.9 d](/filings/0001628280-25-050104.md) | [16.2 d](/filings/0000096869-25-000006.md) | [17.5](/filings/0001628280-25-023871.md) | [19.6 d](/filings/0000096869-25-000032.md) | [12.2 d](/filings/0001628280-25-050104.md) | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [26.5](/filings/0000096869-23-000017.md) | [26.6](/filings/0000096869-24-000008.md) | [26.8](/filings/0000096869-24-000011.md) | [26.8](/filings/0000096869-24-000014.md) | [26.8](/filings/0001628280-25-023871.md) | [26.8](/filings/0000096869-25-000032.md) | [26.8](/filings/0001628280-25-050104.md) | [26.9](/filings/0001628280-26-033234.md) | [26.9](/filings/0001628280-26-054146.md) | [26.9](/filings/0001628280-25-050104.md) | [27.0](/filings/0001628280-26-033234.md) | [27.1](/filings/0001628280-26-054146.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 27,021,444 at 2026-08-03, from the cover of the [10-Q filed 2026-08-06](/filings/0001628280-26-054146.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:20 ET. No prices; not investment advice.